Dapivirine Vaginal Ring: A long-acting ring for women's HIV prevention

Authors

IPM South Africa

Document Type

Fact Sheet

Publication Date

10-1-2024

Abstract

Despite progress against HIV/AIDS, women continue to face persistently high infection rates, particularly in sub-Saharan Africa. The monthly dapivirine vaginal ring, developed by International Partnership for Microbicides (IPM) and acquired by the Population Council, adapts a medical technology commonly used to deliver hormones to women—a vaginal ring—in response to high HIV infection rates in women. The DVR could fill an important gap for women who are unable or choose not to use other available products.

Recommended Citation

IPM South Africa. 2024. "Dapivirine Vaginal Ring: A long-acting ring for women's HIV prevention," factsheet. Population Council.

Language

English

Project

The Dapivirine Vaginal Ring for HIV Prevention